Tokyo, Japan

Toshiko Sakihama

This inventor holds 1 USPTO granted patent. Top assignees: Perseus Proteomics Inc., The University of Tokyo. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toshiko Sakihama. Retrieved from https://idiyas.com/inventor/toshiko-sakihama

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Toshiko Sakihama: Innovator in Tumor Diagnostics

Introduction

Toshiko Sakihama is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of tumor diagnostics, particularly through his innovative work involving antibodies.

Latest Patents

Sakihama holds a patent for a tumor diagnostic agent used in PET, which comprises an anti-ROBO1 antibody. The objective of this invention is to provide a novel antibody capable of specifically recognizing ROBO1, which is expressed in cell membranes. This patent includes a hybridoma that produces the antibody, a method for its production, and the diagnostic agent itself. The monoclonal antibody developed by Sakihama is capable of specifically recognizing ROBO1 on the surface of cells, obtained by immunizing an animal with a ROBO1-displaying baculovirus.

Career Highlights

Throughout his career, Sakihama has worked with prestigious institutions, including The University of Tokyo and Perseus Proteomics Inc. His research has focused on advancing the understanding and detection of tumors, contributing to the medical field's diagnostic capabilities.

Collaborations

Sakihama has collaborated with Hiroko Iwanari, who has also contributed to his research endeavors.

Conclusion

Toshiko Sakihama's work in developing a tumor diagnostic agent showcases his innovative spirit and dedication to improving medical diagnostics. His contributions are significant in the ongoing fight against cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…